Item Type | Name |
Concept
|
Chronic Disease
|
Concept
|
Coronary Disease
|
Concept
|
Musculoskeletal Diseases
|
Concept
|
Mixed Connective Tissue Disease
|
Concept
|
Rheumatic Diseases
|
Concept
|
Vascular Diseases
|
Concept
|
Skin Diseases, Vascular
|
Concept
|
Virus Diseases
|
Concept
|
Disease Progression
|
Concept
|
Autoimmune Diseases
|
Concept
|
Gastrointestinal Diseases
|
Academic Article
|
Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
|
Academic Article
|
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures.
|
Academic Article
|
The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
|
Academic Article
|
Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
|
Academic Article
|
Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease.
|
Academic Article
|
Successful use of rituximab for cutaneous vasculitis.
|
Academic Article
|
Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties.
|
Academic Article
|
Improving patient reported outcomes using item response theory and computerized adaptive testing.
|
Academic Article
|
Viral infection and reactivation in autoimmune disease.
|
Academic Article
|
Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases.
|
Academic Article
|
Management of rheumatic diseases during pregnancy.
|
Academic Article
|
Pregnancy outcomes after maternal exposure to rituximab.
|
Academic Article
|
Pre-disease pregnancy complications and systemic sclerosis: pathogenic or pre-clinical?
|
Academic Article
|
Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives.
|
Academic Article
|
Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.
|
Academic Article
|
Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease.
|
Academic Article
|
The impact of menopause on functional status in women with rheumatoid arthritis.
|
Academic Article
|
ARID3a gene profiles are strongly associated with human interferon alpha production.
|
Academic Article
|
Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease.
|
Academic Article
|
Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.
|
Academic Article
|
Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans.
|
Academic Article
|
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
|
Academic Article
|
Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases.
|
Academic Article
|
The Herpes Zoster Vaccine in Rheumatic Diseases: Duration of Response.
|
Academic Article
|
Use of Administrative Databases to Assess Reproductive Health Issues in Rheumatic Diseases.
|
Academic Article
|
Rheumatic syndromes associated with malignancy.
|
Academic Article
|
Coronary artery disease in patients with systemic lupus erythematosus.
|
Academic Article
|
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial.
|
Academic Article
|
Reproductive Health Screening in Women with Autoimmune Diseases.
|
Academic Article
|
Reproductive Rheumatology: Meeting Today's Challenges.
|
Academic Article
|
The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.
|
Academic Article
|
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus.
|